Effectiveness and cost‐effectiveness of home palliative care services for adults with advanced illness and their caregivers

B Gomes, N Calanzani, V Curiale… - Cochrane Database …, 2013 - cochranelibrary.com
Background Extensive evidence shows that well over 50% of people prefer to be cared for
and to die at home provided circumstances allow choice. Despite best efforts and policies …

Polypharmacy and potentially inappropriate medication use in geriatric oncology

M Sharma, KP Loh, G Nightingale, SG Mohile… - Journal of geriatric …, 2016 - Elsevier
Polypharmacy is a highly prevalent problem in older persons, and is challenging to assess
and improve due to variations in definitions of the problem and the heterogeneous methods …

Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial

JS Kutner, PJ Blatchford, DH Taylor… - JAMA internal …, 2015 - jamanetwork.com
Importance For patients with limited prognosis, some medication risks may outweigh the
benefits, particularly when benefits take years to accrue; statins are one example. Data are …

Mindfulness-based stress reduction and mindfulness-based cognitive therapy with older adults: A qualitative review of randomized controlled outcome research

H Hazlett-Stevens, J Singer, A Chong - Clinical gerontologist, 2019 - Taylor & Francis
Objective: Many older adults cope with various chronic physical health conditions, and in
some cases, with mental health and/or cognitive difficulties. Mindfulness-based interventions …

Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain

J Hardy, S Quinn, B Fazekas, J Plummer… - Journal of clinical …, 2012 - ascopubs.org
Purpose The anesthetic ketamine is widely used for pain related to cancer, but the evidence
to support its use in this setting is weak. This study aimed to determine whether ketamine is …

Polypharmacy in patients with advanced cancer and the role of medication discontinuation

TW LeBlanc, MJ McNeil, AH Kamal, DC Currow… - The Lancet …, 2015 - thelancet.com
Polypharmacy is a well known problem in elderly patients in general, but its prevalence and
effects in patients with cancer are less clear, particularly in end-of-life settings. This Review …

Studies to reduce unnecessary medication use in frail older adults: a systematic review

J Tjia, SJ Velten, C Parsons, S Valluri, BA Briesacher - Drugs & aging, 2013 - Springer
Background Overuse of unnecessary medications in frail older adults with limited life
expectancy remains an understudied challenge. Objective To identify intervention studies …

[HTML][HTML] The burden of polypharmacy in patients near the end of life

MJ McNeil, AH Kamal, JS Kutner, CS Ritchie… - Journal of pain and …, 2016 - Elsevier
Context Patients with advanced illness are prescribed multiple medications in the last year
of life, intensifying the risk of negative consequences related to polypharmacy. Objectives To …

Prevalence and factors associated with polypharmacy in older people with cancer

JP Turner, S Shakib, N Singhal, J Hogan-Doran… - Supportive Care in …, 2014 - Springer
Purpose Polypharmacy has been associated with drug–drug interactions, adverse drug
events, hospitalisation and increased mortality. The purpose of this study was to investigate …

Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use

HM Holmes, GA Sachs, JW Shega… - Journal of the …, 2008 - Wiley Online Library
OBJECTIVES: To evaluate the feasibility of developing consensus recommendations for
appropriate prescribing for patients with advanced dementia using a new conceptual …